Heart failure in 2010: One step forward, two steps back

Nature Reviews Cardiology

Volumn 8, Issue 2, 2011, Pages 72-74

  Gheorghiade, Mihai ^a   Ambrosy, Andrew ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; EPLERENONE; IVABRADINE; MINERALOCORTICOID ANTAGONIST; PLACEBO; ROLOFYLLINE;

CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL RESEARCH; DRUG DOSE TITRATION; DRUG MECHANISM; HEART FAILURE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYPERKALEMIA; MORTALITY; OUTPATIENT CARE; PRIORITY JOURNAL; REVIEW; SEIZURE; STROKE; SURVIVAL RATE;

HEART FAILURE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79251627885     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2010.205     Document Type: Review

References (10)

1. Gheorghiade, M. & Pang, P. S. acute heart failure syndromes. J. Am. Coll. Cardiol. 53, 557-573 (2009).
2. Swedberg, K. et al. ivabradine and outcomes in chronic heart failure (SHiFT): a randomised placebo-controlled study. Lancet 376, 875-885 (2010).
3. Zannad, F. et al. eplerenone in patients with systolic heart failure and mild symptoms. N. Engl. J. Med. doi:10.1056/neJMoa1009492.
4. Tang, A. S. et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N. Engl. J. Med. 363, 2385-2395 (2010).
5. Massie, B. M. et al. rolofylline, an adenosine a1-receptor antagonist, in acute heart failure. N. Engl. J. Med. 363, 1419-1428 (2010).
6. Pitt, B. et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. randomized aldactone evaluation Study investigators. N. Engl. J. Med. 341, 709-717 (1999).
7. Pitt, B. et al. eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 348, 1309-1321 (2003).
8. Juurlink, D. N. et al. rates of hyperkalemia after publication of the randomized aldactone evaluation Study. N. Engl. J. Med. 351, 543-551 (2004).
9. Cotter, G. et al. The PrOTeCT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine a1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment. J. Card. Fail. 14, 631-640 (2008).
10. Hernandez, A. F. acute Study of Clinical effectiveness of nesiritide in Decompensated Heart Failure Trial (aSCenD-HF). Presented at the 2010 aHa Scientific Sessions, Chicago, iL, USa.